UCB plans to submit for regulatory approval of fenfluramine for the treatment of seizures associated with CDKL5 Deficiency Disorder (CDD) as soon as possible, marking fenfluramine's third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback